ArticleBMC genomics2026
Dissecting the expression pattern during embryonic development and unveiling sustained ZGA genes with oncogenic relevance.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundZygotic genome activation (ZGA) represents a pivotal transition in early embryonic development, marking the onset of gene expression following fertilization. Despite its fundamental importance, precisely determining the timing and identifying the key genes involved in ZGA remains a significant challenge.
resultsBased on time-course patterns from RNA-seq data spanning all developmental stages, we proposed a computational framework to identify ZGA genes and the onset of ZGA across diverse species. In mice, we identified 690 ZGA-associated genes, 119 of which were previously uncharacterized. Furthermore, we defined a pivotal gene subset termed Sustained ZGA (S-ZGA) genes, which are activated from ZGA and maintain sustained expression throughout subsequent development. Epigenetic analyses revealed that promoter accessibility and H3K4me3 enrichment are primary regulatory mechanisms for S-ZGA genes. Notably, these genes exhibit strong enrichment in tumorigenesis and metastatic processes.
conclusionThis study establishes a computational framework that operates independently of prior knowledge to identify ZGA genes and precisely determine ZGA onset timing across diverse species, and defines a critical subset termed Sustained ZGA (S-ZGA) genes, which are potentially associated with tumorigenesis and metastatic processes. These findings provide a novel perspective on the molecular mechanisms underlying both normal development and cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.